Tirzepatide is a synthetic dual agonist of the glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors. In research studies, it has been investigated for its role in regulating blood glucose levels, improving insulin sensitivity, and influencing energy balance. Its dual receptor activity has also been studied for potential effects on body weight and metabolic function.
All peptides are sold in kits of 10 vials only. Price is for 10 vials of desired size. All peptides come as a lyophilised powder that needs to be reconstituted with bacteriostatic water.
